Cargando…
P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430472/ http://dx.doi.org/10.1097/01.HS9.0000847520.82769.e5 |
| _version_ | 1784779777514668032 |
|---|---|
| author | Albanyan, O. Castaneda-Puglianini, O. Chavez, J. |
| author_facet | Albanyan, O. Castaneda-Puglianini, O. Chavez, J. |
| author_sort | Albanyan, O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430472 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94304722022-08-31 P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY Albanyan, O. Castaneda-Puglianini, O. Chavez, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430472/ http://dx.doi.org/10.1097/01.HS9.0000847520.82769.e5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Albanyan, O. Castaneda-Puglianini, O. Chavez, J. P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title | P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title_full | P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title_fullStr | P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title_full_unstemmed | P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title_short | P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY |
| title_sort | p1163: outcomes of high-risk large b-cell lymphoma treated with standard of care chemoimmunotherapy: a non-randomized comparison to frontline car-t cell therapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430472/ http://dx.doi.org/10.1097/01.HS9.0000847520.82769.e5 |
| work_keys_str_mv | AT albanyano p1163outcomesofhighrisklargebcelllymphomatreatedwithstandardofcarechemoimmunotherapyanonrandomizedcomparisontofrontlinecartcelltherapy AT castanedapuglianinio p1163outcomesofhighrisklargebcelllymphomatreatedwithstandardofcarechemoimmunotherapyanonrandomizedcomparisontofrontlinecartcelltherapy AT chavezj p1163outcomesofhighrisklargebcelllymphomatreatedwithstandardofcarechemoimmunotherapyanonrandomizedcomparisontofrontlinecartcelltherapy |